AXA (EPA:CS) Receives “Neutral” Rating from DZ Bank

AXA (EPA:CS)‘s stock had its “neutral” rating restated by analysts at DZ Bank in a research report issued on Wednesday, January 3rd.

A number of other equities research analysts have also weighed in on CS. Citigroup set a €26.20 ($31.19) target price on AXA and gave the company a “neutral” rating in a research note on Friday, September 8th. Deutsche Bank set a €27.50 ($32.74) price target on AXA and gave the company a “buy” rating in a research report on Friday, September 8th. Barclays set a €26.00 ($30.95) price target on AXA and gave the company a “buy” rating in a research report on Friday, September 8th. Royal Bank of Canada set a €28.00 ($33.33) target price on AXA and gave the stock a “buy” rating in a report on Wednesday, September 13th. Finally, Kepler Capital Markets set a €29.80 ($35.48) target price on AXA and gave the stock a “buy” rating in a report on Thursday, September 28th. Five analysts have rated the stock with a hold rating and thirteen have given a buy rating to the company. The stock has a consensus rating of “Buy” and a consensus target price of €27.68 ($32.95).

Shares of AXA (EPA:CS) opened at €26.86 ($31.98) on Wednesday. AXA has a 52 week low of €21.81 ($25.96) and a 52 week high of €27.04 ($32.19). The firm has a market capitalization of $65,140.00 and a PE ratio of 11.43.

ILLEGAL ACTIVITY NOTICE: “AXA (EPA:CS) Receives “Neutral” Rating from DZ Bank” was originally posted by The Ledger Gazette and is the property of of The Ledger Gazette. If you are viewing this news story on another domain, it was stolen and republished in violation of U.S. and international copyright laws. The original version of this news story can be accessed at https://ledgergazette.com/2018/01/13/axas-cs-neutral-rating-reiterated-at-dz-bank.html.

About AXA

AXA SA (AXA) is a France-based holding company engaged in the business of financial protection. The Company’s segments include Life & Savings, Property & Casualty, Asset Management , Banking and Holding companies. The Life & Savings segment’s products include a range of investment and savings products, as well as Protection and Health products.

Analyst Recommendations for AXA (EPA:CS)

Receive News & Ratings for AXA Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for AXA and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply